Related Experiment Video
Updated: May 5, 2026

Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles
Published on: September 27, 2013
Stimuli-responsive polymer-based nanosystems for cardiovascular disease theranostics
Yuying Liu1,2, Congcong Li1, Xiao Yang1
1Institute for Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao 266021, China. fuqinrui20222@qdu.edu.cn.
Stimulus-responsive polymers are revolutionizing drug delivery for atherosclerotic cardiovascular diseases (CVDs). These smart nanocarriers precisely target inflammatory lesions, enhancing diagnosis and treatment with improved safety and versatility.
Area of Science:
- Biomedical Engineering
- Materials Science
- Nanotechnology
Background:
- Stimulus-responsive polymers change structure in response to internal (pH, ROS, enzymes) or external (light) triggers.
- These polymers are crucial for developing smart nanocarriers for targeted drug delivery in atherosclerotic cardiovascular diseases (CVDs).
- Stimulus-responsive nanosystems offer advantages over traditional methods, including higher sensitivity, versatility, applicability, and biosafety.
Purpose of the Study:
- To review recent advancements in stimulus-responsive polymer nanosystems for CVDs diagnosis and treatment.
- To classify nanocarriers based on responsiveness types and relevant stimuli.
- To discuss applications in CVDs theranostics.
Main Methods:
- Literature review of recent research on stimulus-responsive polymers for CVDs.
- Classification of nanocarriers by responsiveness and stimuli.
- Discussion of theranostic applications.
Main Results:
- Significant progress has been made in designing stimulus-responsive polymer nanosystems for CVDs.
- Various stimuli (pH, ROS, enzymes, light) are utilized for targeted drug delivery.
- These systems show promise for both diagnosing and treating CVDs.
Conclusions:
- Stimulus-responsive polymers offer a promising platform for advanced CVDs theranostics.
- Optimizing nanocarrier design is key to accelerating clinical translation.
- Further research can enhance the efficacy and safety of these smart materials for cardiovascular health.
Related Concept Videos
Modified-Release Drug Delivery Systems: Stimuli-Activated
Site-Targeted Drug Delivery Systems: Polymeric Carriers

